End-stage liver disease and acute liver failure
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients who need an MRI after a liver transplant; 2. Age/Gender: Not limited; 3. Patients who voluntarily participate in a clinical trial and have signed a written informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients with a pacemaker, unknown implants, metal implants in the body, neurostimulators, or claustrophobia, etc. 2. Patients who cannot hold their breath long enough to complete a full MRI scan.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quantitative parameters of functional MRI sequences (e.g.ADC, R2*); | — |
Secondary
| Measure | Time frame |
|---|---|
| Laboratory indicators of liver and kidney function (ALT, AST, TBIL, PT, eGFR, etc.);Quantitative indicators of body composition (fat content, muscle content, and radiation density, etc.); | — |
Countries
China
Contacts
Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology